DK125623B - Fremgangsmåde til overtrækning af partikler af penicilliner. - Google Patents

Fremgangsmåde til overtrækning af partikler af penicilliner.

Info

Publication number
DK125623B
DK125623B DK417468AA DK417468A DK125623B DK 125623 B DK125623 B DK 125623B DK 417468A A DK417468A A DK 417468AA DK 417468 A DK417468 A DK 417468A DK 125623 B DK125623 B DK 125623B
Authority
DK
Denmark
Prior art keywords
penicillins
coating particles
particles
coating
Prior art date
Application number
DK417468AA
Other languages
Danish (da)
English (en)
Inventor
A Granatek
M Demurio
B Nunning
N Athanas
R Dana
E Granatek
R Daoust
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK125623B publication Critical patent/DK125623B/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK417468AA 1964-05-20 1968-08-30 Fremgangsmåde til overtrækning af partikler af penicilliner. DK125623B (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US36899164A 1964-05-20 1964-05-20
US66529767A 1967-09-05 1967-09-05
US67998267A 1967-11-02 1967-11-02
US68000867A 1967-11-02 1967-11-02

Publications (1)

Publication Number Publication Date
DK125623B true DK125623B (da) 1973-03-19

Family

ID=31950768

Family Applications (1)

Application Number Title Priority Date Filing Date
DK417468AA DK125623B (da) 1964-05-20 1968-08-30 Fremgangsmåde til overtrækning af partikler af penicilliner.

Country Status (11)

Country Link
BE (1) BE719923A (de)
DE (1) DE1792365A1 (de)
DK (1) DK125623B (de)
FI (1) FI48039C (de)
FR (1) FR1605499A (de)
GB (1) GB1246489A (de)
IE (1) IE32916B1 (de)
IL (1) IL30627A (de)
NL (1) NL141779B (de)
NO (1) NO126299B (de)
SE (1) SE363974B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1532993A (en) * 1975-03-07 1978-11-22 Beecham Group Ltd Injectable antibiotic compositions
GB1598458A (en) * 1977-04-01 1981-09-23 Hoechst Uk Ltd Tableting of microcapsules
US7799342B2 (en) * 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet

Also Published As

Publication number Publication date
NL141779B (nl) 1974-04-16
GB1246489A (en) 1971-09-15
FI48039C (fi) 1974-06-10
NO126299B (de) 1973-01-22
FI48039B (de) 1974-02-28
IE32916L (en) 1969-05-02
SE363974B (de) 1974-02-11
NL6812651A (de) 1969-03-07
DE1792365A1 (de) 1972-03-09
FR1605499A (de) 1977-06-24
IL30627A (en) 1973-02-28
IL30627A0 (en) 1968-10-24
IE32916B1 (en) 1974-01-23
BE719923A (de) 1969-02-24

Similar Documents

Publication Publication Date Title
DK115924B (da) Fremgangsmåde til fremstilling af β-karbolinderivater.
DK115704B (da) Fremgangsmåde til fremstilling af 2-aryl-nitroimidazolforbindelser.
DK108487C (da) Fremgangsmåde til fremstilling af alkalifattigt cement.
DK138330B (da) Fremgangsmåde til fremstilling af penicilliner.
DK113434B (da) Fremgangsmåde til fremstilling af 5-nitro-imidazolforbindelser.
DK118018B (da) Fremgangsmåde til fremstilling af diorganoantimonforbindelser.
DK120194B (da) Fremgangsmåde til fremstilling af azirindinderivater.
DK118019B (da) Fremgangsmåde til fremstilling af diorganoantimonforbindelser.
DK110033C (da) Fremgangsmåde til fremstilling af antibioticet Rhi-12-648.
DK114699B (da) Fremgangsmåde til fremstilling af furylbenzofuranderivater.
DK114402B (da) Fremgangsmåde til fremstilling af et enzymkompleks.
DK115108B (da) Fremgangsmåde til fremstilling af 2-amino-benzophenon-β-oximer.
DK125623B (da) Fremgangsmåde til overtrækning af partikler af penicilliner.
DK116513B (da) Analogifremgangsmåde til fremstilling af substituerede o-phenoxy-phenylestere.
DK119708B (da) Fremgangsmåde til fremstilling af thiaminderivater.
DK122071B (da) Analogifremgangsmåde til fremstilling af methylenbutyrylphenoler.
DK111891B (da) Fremgangsmåde til fremstilling af 5-oxo-17α-methyl-20-hydroxy-(des-A)-19-nor-pregna-9-en.
DK115694B (da) Fremgangsmåde til fremstilling af α-dithioler.
DK112318B (da) Fremgangsmåde til fremstilling af 2-benzensulfonylamidopyrimidiner.
DK116271B (da) Fremgangsmåde til isolering af bacitracin.
DK118945B (da) Fremgangsmåde til fremstilling af 3-phenylpyrrol-derivater.
DK119053B (da) Fremgangsmåde til kontinuerlig fremstilling af monoolefiner.
DK120085B (da) Fremgangsmåde til fremstilling af mitosanforbindelser.
DK109140C (da) Fremgangsmåde til fremstilling af 1-hydroksy-3-aminopyrrolidon-2-derivater.
DK111884B (da) Fremgangsmåde til fremstilling af estere.